Form 4: Medpace Holdings Director Exercises Stock Options

Cornelius P. McCarthy III, a director at Medpace Holdings, exercised stock options on September 30, 2024, acquiring 62 shares of common stock.

Summary

• On September 30, 2024, Cornelius P. McCarthy III, a director of Medpace Holdings, Inc., executed a transaction involving derivative securities.
• Specifically, McCarthy exercised 62 restricted stock units, each representing a contingent right to receive one share of MEDP common stock.
• These restricted stock units were part of a grant made on November 30, 2023, vesting in four approximately equal installments.
• The vesting schedule included March 31, 2024, June 30, 2024, September 30, 2024, and December 31, 2024.
• Following the transaction, McCarthy directly owns 5,225 shares of Medpace Holdings common stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing, reflecting a neutral sentiment. It simply reports a transaction.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company insiders.

Stakeholder Impact

• The transaction has a minimal direct impact on stakeholders, as it is a routine exercise of stock options by a director.

Key Dates